60 related articles for article (PubMed ID: 15468568)
21. Toward vaccines against cervical cancer.
Jansen KU
Curr Opin Drug Discov Devel; 2004 Mar; 7(2):228-32. PubMed ID: 15603257
[TBL] [Abstract][Full Text] [Related]
22. Human papillomavirus, it's genes...and cancer vaccines.
Steller MA
Cancer Cell; 2003 Jan; 3(1):7-8. PubMed ID: 12559170
[TBL] [Abstract][Full Text] [Related]
23. An overview of human papillomaviruses and current vaccine strategies.
Gnanamony M; Peedicayil A; Abraham P
Indian J Med Microbiol; 2007 Jan; 25(1):10-7. PubMed ID: 17377346
[TBL] [Abstract][Full Text] [Related]
24. Vaccine against papilloma virus: a review of the clinical studies.
Gabutti G
J Prev Med Hyg; 2009 Jun; 50(2):79-89. PubMed ID: 20099437
[No Abstract] [Full Text] [Related]
25. Using the new HPV vaccines in clinical practice.
Widdice LE; Kahn JA
Cleve Clin J Med; 2006 Oct; 73(10):929-35. PubMed ID: 17044318
[TBL] [Abstract][Full Text] [Related]
26. [A vaccine against papillomavirus infections and cancer].
Lehtinen M; Apter D; Heikkilä R; Heino P; Idänpään-Heikkilä I; Rimpilä K; Malm C; Zilliacus R
Duodecim; 2002; 118(13):1397-404. PubMed ID: 12239887
[No Abstract] [Full Text] [Related]
27. How will HPV vaccines affect cervical cancer?
Roden R; Wu TC
Nat Rev Cancer; 2006 Oct; 6(10):753-63. PubMed ID: 16990853
[TBL] [Abstract][Full Text] [Related]
28. Prospects for human papillomavirus vaccine development: emerging HPV vaccines.
Hines JF; Ghim SJ; Jenson AB
Curr Opin Obstet Gynecol; 1998 Feb; 10(1):15-9. PubMed ID: 9484624
[TBL] [Abstract][Full Text] [Related]
29. Strengthening prevention programs to eliminate cervical cancer in the Nordic countries.
Dillner L; Pagliusi S; Bray F; Lorincz A; Kjaer SK; Anttila A; Iversen OE; Dillner J; Lehtinen M; Paavonen J
Acta Obstet Gynecol Scand; 2008; 87(5):489-98. PubMed ID: 18446530
[TBL] [Abstract][Full Text] [Related]
30. Human papillomavirus vaccines for the prevention and treatment of cervical cancer.
Tomson TT; Roden RB; Wu TC
Curr Opin Investig Drugs; 2004 Dec; 5(12):1247-61. PubMed ID: 15648945
[TBL] [Abstract][Full Text] [Related]
31. [Recombinant therapeutic vaccines against cancer of the uterine cervix].
Berumen J; Villegas N
Salud Publica Mex; 1997; 39(4):288-97. PubMed ID: 9381250
[TBL] [Abstract][Full Text] [Related]
32. Human papillomavirus infection and cervical carcinoma.
Kaufman RH; Adam E; Vonka V
Clin Obstet Gynecol; 2000 Jun; 43(2):363-80. PubMed ID: 10863634
[No Abstract] [Full Text] [Related]
33. HPV vaccines.
Stanley M
Best Pract Res Clin Obstet Gynaecol; 2006 Apr; 20(2):279-93. PubMed ID: 16356772
[TBL] [Abstract][Full Text] [Related]
34. [Perspectives for the development of vaccines and immunotherapy against cervico-uterine cancer].
Guzmán-Rojas L; Alcocer-González JM; Madrid-Marina V
Salud Publica Mex; 1998; 40(1):38-46. PubMed ID: 9567657
[TBL] [Abstract][Full Text] [Related]
35. Preventive vaccines for cervical cancer.
Wheeler CM
Salud Publica Mex; 1997; 39(4):283-7. PubMed ID: 9337561
[TBL] [Abstract][Full Text] [Related]
36. Papillomavirus-like particle vaccines for cervical cancer.
Schiller JT
Mol Med Today; 1999 May; 5(5):209-15. PubMed ID: 10322313
[TBL] [Abstract][Full Text] [Related]
37. Human papillomavirus vaccines.
Stanley MA
Rev Med Virol; 2006; 16(3):139-49. PubMed ID: 16710836
[TBL] [Abstract][Full Text] [Related]
38. Human papillomavirus infection: an old disease, a new vaccine.
Giles M; Garland S
Aust N Z J Obstet Gynaecol; 2006 Jun; 46(3):180-5. PubMed ID: 16704468
[TBL] [Abstract][Full Text] [Related]
39. Developments in L2-based human papillomavirus (HPV) vaccines.
Schellenbacher C; Roden RBS; Kirnbauer R
Virus Res; 2017 Mar; 231():166-175. PubMed ID: 27889616
[TBL] [Abstract][Full Text] [Related]
40. [Immune response in cervical cancer. Strategies for the development of therapeutic vaccines].
Mora-García ML; Monroy-García A
Rev Med Inst Mex Seguro Soc; 2015; 53 Suppl 2():S206-11. PubMed ID: 26462518
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
